QuidelOrtho ‘vulnerable to an approach,’ says Gordon Haskett

Gordon Haskett’s head of event-driven research Don Bilson contends that following last Wednesday’s 32% selloff and the parting of ways with CEO Doug Bryant, QuidelOrtho is “vulnerable to an approach” and notes that last Wednesday’s high-volume selloff following Q4 results “came two days before the nomination window closed.” The firm adds: “Something to watch now is whether an opportunistic buyer – either a strategic or a sponsor – tries to take advantage of this headless situation. We’d put our money on the latter.”